Scangenie Scientific Private Limited is developing Raksha, an AI-powered, non-invasive oral cancer screening device designed to support the early identification of suspicious changes in oral tissue. The device is a portable handheld solution that combines specialized illumination, optical imaging, and artificial intelligence to capture and analyse images of the oral mucosa. Raksha is designed to assist in the classification of oral lesions into Normal, Pre-Malignant, and Malignant categories, providing a rapid and technology-driven screening approach for healthcare professionals. The system combines a handheld imaging device with an AI-based software platform that processes captured images and provides an assessment to support clinical decision-making. The innovation focuses on addressing the need for accessible, portable, radiation-free, and affordable oral cancer screening, particularly in healthcare settings where advanced diagnostic facilities may not be readily available. Raksha can be used in hospitals, dental clinics, primary healthcare centres, community screening programmes, and cancer-screening camps. Scangenie aims to develop Raksha into a practical medical technology solution that can support early screening, timely identification of high-risk oral lesions, and appropriate referral for further diagnostic evaluation. Through the integration of optical technology and artificial intelligence, the company seeks to improve the accessibility and efficiency of oral cancer screening and contribute to better healthcare outcomes.
Show MoreYear of Establishment2024